Expert Speakers

Thorsten Gorba

Vice President, Manufacturing

Aspen Neuroscience

Xiaokui Zhang

Chief Scientific Officer

Aspen Neuroscience

Jordan Lancaster

Chief Executive Officer

Avery Therapeutics

Byeongtaek Oh

Associate Director, Regulatory Affairs

BlueRock Therapeutics

Adrienne Farid

Chief Operating Officer

Century Therapeutics

Kilian Kelly

Chief Operating Officer

Cynata Therapeutics

Daniel Teper

Co-Founder & Chief Executive Officer

Cytovia Therapeutics

Wei Li

Chief Scientific Officer

Cytovia Therapeutics

Gregory Fiore

Chief Executive Officer

Exacis Biotherapeutics

George Daley

Dean of Faculty of Medicine

Harvard Medical School

Hardy Kagimoto

Founder, Chairman & Chief Executive Officer

Healios K.K.

John Lu

President & Chief Executive Officer

HebeCell

Lawrence Lamb

Chief Scientific Officer & Executive Vice President

IN8Bio

Kate Rochlin

Chief Operating Officer

IN8Bio

Carlos Obejero-Paz

Associate Director

Khloris Biosciences

Joseph Wu

Co-Founder
Khloris Biosciences
Director

Stanford Cardiovascular Institute

David Main

President & Chief Executive Officer

Notch Therapeutics

Jacob Sten

Petersen Head of Cell Therapy Research & Development

Novo Nordisk

Sonja Schrepfer

Scientific Founder, Senior Vice President & Head of Hypoimmune Platform

Sana Biotechnology

Fabian Zanella

Director, Analytic Testing

Sana Biotechnology

Jonathan Gilbert

Vice President, Exploratory Research

SQZ Biotech

Benjamin Gysi

Director, Cell Therapy Operations

Takeda

Luis Borlado

Head, Cell Therapy Product Development Research

Takeda

Xi Shi

Associate Director, Platform Design & Genetic Engineering, Oncology Cell Therapies

Takeda

Yu Qian

Associate Director, Oncology Cell Therapies

Takeda

Ryan Crisman

Co-Founder & Chief Technical Officer

Umoja Biopharma

Rita Perlingeiro

Professor of Medicine, Cardiovascular Division

University of Minnesota

Peter Andersen

Co-Founder & Chief Scientific Officer

Vita Therapeutics